Home Stock Market Global COVID-19 cases peaked at 133 million when Brazil and India hit...

Global COVID-19 cases peaked at 133 million when Brazil and India hit the spotlight

Globally confirmed cases of COVID-19 coronavirus disease rose to over 133 million on Thursday and deaths increased by nearly 3 million, as India and Brazil hit the spotlight amid record mortality. and concerns about the spread of more infectious variants.

Brazil reported nearly 4,200 deaths from COVID-19 on Tuesday, according to the Washington Post, highest number in one day since the beginning of the pandemic. The country is struggling to stop the P.1 variant and is also currently dealing with the first variant found in South Africa.

President Jair Bolsanaro has been widely criticized for his leisurely approach to the crisis, leaving Brazil with the second highest number of cases in the world after the US, according to data compiled by Johns Hopkins University, and the second highest death toll.

Officials in Brazil’s most populous city, São Paulo, say they are adding 600 new graves to the city cemeteries each day.

Johns Hopkins data shows that India has the third highest number of cases and the fourth highest number of deaths. India recorded more than 126,000 new cases on Thursday, a record increase in one day. The country of 1.36 billion people is believed to be in a vaccine shortage with about 700 million people, after exporting the dose produced by the Serum Institute of India, the world’s largest vaccine maker.

The government is blaming the increase in crowding and reluctance to wear masks as shops and offices have reopened, Reuters reported.

Prime Minister Narendra Modi received a second round of injections on Thursday.

Europe’s vaccine disaster continued on Thursday, with Spain and Italy deciding to limit the use of vaccines developed by AstraZeneca PLC and University of Oxford for people over 60, MarketWatch’s Lina Saigol reported. That is expected to continue to slow the European Union’s slow immunization program, which lags behind countries including the US, UK and Israel. The US and UK have been charged with vaccines because both countries are slow to export dosages.

Italy and Spain made their decision on Wednesday after the European Medicines Agency (EMA) said they had found possible link between the pharmaceutical company AstraZeneca’s
+ 2.50%

+ 1.85%

vaccines and very rare cases of blood clotting problems in adults. EMA recommends not to limit age, as it emphasizes that the benefits of shooting outweigh the risks.

Read: European Union and UK regulators say the AstraZeneca vaccine is safe, but Britons under 30 will be given an alternative shot.

Last month, and French German health official Limit the use of AstraZeneca injections to those over 55 and over 60 years of age, following concerns about abnormal clotting in some recipients.

According to a New York Times report, the US had an additional 73,200 new cases on Wednesday, and at least 2,564 people died. That death count is artificially increased by “more deaths from unknown days”, trackers are showing.

But the seven-day average was 65,556, up 14% from the 14-day average, a trend that worries health professionals as more young people get sick and get more illnesses. more contagious.

CDC director Dr Rochelle Walensky on Wednesday said variant B.1.1.7, identified for the first time in the UK, iCurrently the most dominant form of coronavirus circulating in the United States Walensky says communities with a high rate of community transmission should not allow teen sports indoors or allow six feet distance. She also said that major events in those communities should be postponed.

In other news:

The Australian government said Thursday the coronavirus Pfizer vaccine should be used for those under 50 years of age instead of a vaccine made by AstraZeneca, changing advice for those considered at highest risk, Reuters reported. The move is a setback for Australia’s faltering vaccination effort, which relies heavily on the AstraZeneca vaccine. Health Director Paul Kelly said Australia would advise healthcare providers to only give the first dose of AstraZeneca vaccine to adults under the age of 50 when the benefits clearly outweigh the risks. Those who took the first dose of AstraZeneca without any serious side effects “can safely get a second dose,” he said.

Do not miss: ‘Terrible’ sales expectations from consumer companies as the COVID schedule closes

The doses of the Russian vaccine they received in Slovakia said “do not have the same characteristics and properties as the version of Sputnik V that was rated by the prestigious medical journal The Lancet. price, New York Times reported. An article that has been reviewed in a magazine published in February Sputnik V showed 91% effectiveness against the virus, a statistic that helped convince Slovakia to become one of the two EU countries to use it. The vaccine manufacturer was not impressed by the claims:

The death toll from COVID-19 has surpassed 100,000 in Scotland, according to data from the National Records of Scotland. reported by the Guardian. Figures from the Scottish National Records show 38 Covid-19-related deaths were registered between March 29 and April 4, bringing the total number of deaths as of Sunday to 9,997. Since then, six deaths have been recorded in daily data from Public Health Scotland, reported by PA Media.

President Biden on Tuesday announced that he was pushing the deadline from May 1 to April 19 for the states to make all adults in the United States eligible for the Covid-19 vaccine. Photo: Kevin Lamarque / Reuters

Eli Lilly & Co.
+ 0.67%

and Incyte Corp.

said Thursday a phase 3 trial of baricitinib rheumatoid arthritis plus standard of care (SoC) versus placebo plus SoC not reaching its main goal. The primary criterion of the trial identified was the difference in the number of patients requiring non-invasive ventilation including high-flow oxygen, either invasive mechanical ventilation, or death on day 28. baricitinib had little risk of progression to ventilation or death, a difference that was not statistically significant. Trials with 1,525 patients showed a 38% reduction in mortality by Day 28 in patients treated with baricitinib plus standard of care, including corticosteroids and remdesivir.

French church and government leaders expressed outrage on Tuesday after images showed a Parisian cathedral celebrating Easter cramped, wearing little masks and no aloofness society defies COVID-19 restrictions, AFP reported. An outcry to service at the Church of Saint-Eugene-Sainte-Cecile comes after an explosive television reportage about secret upscale restaurants operating in the French capital despite the rules . Paris prosecutors told AFP an investigation has been opened against allegations of putting the lives of others at risk from religious activities.

Latest Tallies

According to global statistics for the disease coronavirus caused by the coronavirus rose over 133 million on Thursday, according to data compiled by Johns Hopkins University, while the death toll increased by over 2.88 million.

Nearly 76 million people have recovered from the disease after COVID.

The US continues to lead the world in the number of cases, with 30.9 million people, or about a quarter of all deaths globally and the number of deaths of 559,168.

Brazil had 13.2 million cases and the death toll was 340,776.

India has 12.9 million cases and 166,862 deaths.

Mexico ranked third in the number of deaths with 205,598 people and the 14th highest in the number of cases with 2.3 million people.

The UK has 4.4 million cases and 127,171 deaths, the highest in Europe and the fifth highest in the world.

China, where the virus was first discovered late last year, there have been 101,963 confirmed cases and 4,841 deaths, according to its official numbers, are believed to have not been widely reported.

What does the economy say?

Unemployment claims initially filed across the states rose 16,000 to 744,000 in the week ending April 3, The Labor Department said Thursday, as Greg Robb of MarketWatch reports.

Weekly claims averaged around 220,000 in the year before Covid-19 came along.

Economists surveyed by the Wall Street Journal forecast the new claims will drop to 694,000.

Claims were revised up to 728,000 last week from an earlier estimate of 719,000.

Another 151,752 grant applications were filed last week through a temporary relief program.

see more: This is why concerns about rising inflation are unfounded

Dow Jones industrial average

fell slightly on Thursday, while the S&P 500
+ 0.28%

set a new record for the day.



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments